OUTCOMES IN PATIENTS TREATED WITH RECOMBINANT HUMAN ACTIVATED PROTEIN C AT AN ACADEMIC MEDICAL CENTER VERSUS THE ENHANCE US TRIAL.: 402

This article has no abstract
Epistemonikos ID: e64e8a67f38333485fb2366517d477b4d7dfad84
First added on: Apr 14, 2016